Lupin ties up with Poland-based firm for generic asthama drug
Drug major Lupin has inked a pact with Poland-based Celon Pharma to jointly develop and market a generic version GlaxoSmithKline's Advair Diskus, a drug used to treat asthama, in global markets.
Feb 17, 2015, 15:54 PM IST
EU puts conditions on deals involving Novartis, GSK
The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.
Jan 29, 2015, 00:14 AM IST
More unit IPOs an option for evolving GlaxoSmithKline
GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this offers value to shareholders.
Jan 16, 2015, 18:15 PM IST
Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr
Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.
Jan 13, 2015, 19:15 PM IST
Novartis shares up nearly 2% at close
Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 percent higher Wednesday, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.
Dec 24, 2014, 13:59 PM IST
GSKCH picks Zubair Ahmed for global role in JV with Novartis
The company said it would make a separate announcement of the organisational structure under Ahmed.
Oct 08, 2014, 14:37 PM IST
After China, GlaxoSmithKline faces pressure for change
GlaxoSmithKline may have closed one chapter in a saga of corruption allegations by accepting a $489 million fine in China, but the drugmaker has its work cut out to win back sceptical investors.
Sep 23, 2014, 09:35 AM IST
Drugmaker GSK says fined $490 mn in China graft probe
A Chinese court on Friday fined British drugmaker GlaxoSmithKline 3 billion yuan (USD 490 million) following a nearly year-long bribery probe, the company said.
Sep 19, 2014, 16:27 PM IST
China sentences GSK officials to prison
A Chinese court on Friday sentenced the British former head of drugmaker GlaxoSmithKline`s China operations and other ex-officials to between two and four years in prison, the official Xinhua news agency said.
Sep 19, 2014, 14:28 PM IST
GlaxoSmithKline slashes annual profits forecast
British drugmaker GlaxoSmithKline Wednesday slashed its 2014 profits forecast as second-quarter earnings sank on the back of weak US trade, adverse currency moves and a Chinese bribery probe.
Jul 23, 2014, 21:22 PM IST
